Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCelsius Resources Limited Regulatory News (CLA)

Share Price Information for Celsius Resources Limited (CLA)

Share Price is delayed by 15 minutes
Get Live Data
0.39    0.00 (0.00%)
Bid:
0.35
Ask:
0.43
Spread: 0.08 (22.857%)
Market Cap: £14.52m
CLA Live PriceLast checked at - London Stock Exchange

Intraday Celsius Resources Limited Share Chart

Tranche 2 Placement

15 May 2025 13:27

RNS Number : 8797I
Celsius Resources Limited
15 May 2025
 

 

15 May 2025

 

CELSIUS RESOURCES LIMITED ("Celsius" or the "Company")

 

TRANCHE 2 PLACEMENT

 

 

Celsius Resources Limited (Celsius or CLA) (ASX, AIM:CLA) today makes a further announcement in relation to tranche 2 of the placement announced on 10 March 2025 ("Placement") which raised gross proceeds of approximately A$1.748 million via the placement of 227,917,252 fully paid ordinary shares in the Company ("Shares") at A$0.008 per Share to new and existing shareholders, and institutional investors

 

Application has been made for the Shares, which rank pari passu with existing ordinary shares, to be admitted to trading on AIM ("Admission"). Admission will take place on 16 May 2025.

 

 

This announcement has been authorised by the Board of Directors of Celsius Resources Limited.

 

For further information contact:

 

Celsius Resources Limited

 

 

Mark van Kerkwijk

P: +61 2 8072 1400

E: info@celsiusresources.com.au

W: www.celsiusresources.com

 

Multiplier Media

(Australia Media Contact)

Jon Cuthbert

 

M: +61 402 075 707

E: jon.cuthbert@multiplier.com.au

 

 

Beaumont Cornish Limited

(Nominated Adviser)

Roland Cornish/Felicity Geidt/Andrew Price

 

 

P: +44 (0) 207 628 3396

E: corpfin@b-cornish.co.uk

Zeus Capital Limited

HarryAnsell/JamesJoyce/James Bavister

 

 

P: :+44 (0) 20 3 829 5000

 

 

 

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FUREAASSFADSEFA
Date   Source Headline
15th Aug 202510:45 amRNSIssue of Options
7th Aug 202510:03 amRNSMCB Project activities and funding update
7th Aug 202510:03 amRNSResult of GM
31st Jul 20257:00 amRNSQuarterly Activities Report
14th Jul 202512:35 pmRNSNotice of GM
3rd Jul 20257:00 amRNS-RUpdated Corporate Presentation
27th Jun 20257:00 amRNSFEED and Feasibility Update at MCB Project site
18th Jun 20257:00 amRNSMCB Project Engages Technical Consultants
17th Jun 20257:00 amRNSMCB Project Operational Update
13th Jun 202510:56 amRNSChange of Nominated Adviser
11th Jun 20257:08 amRNSMCB commences drilling program
22nd May 20257:57 amRNSAppendix 2a, Top Holdings, Appendix 3Y, PDMR
19th May 20257:36 amRNSMCB Project advances towards construction
16th May 20259:38 amRNSCompletion of Tranche 2 Placement
15th May 20251:27 pmRNSTranche 2 Placement
15th May 202510:29 amRNSASX Prospectus
9th May 20258:26 amRNSTranche 2 Placement Update
30th Apr 20259:00 amRNSQuarterly Activity Report
28th Apr 202510:11 amRNSResult of Meeting
8th Apr 20257:04 amRNSPH Government confirmation, MMCI capability
7th Apr 20257:08 amRNSASX Trading Halt
28th Mar 20257:30 amRNSNotice of GM
19th Mar 20257:17 amRNSDirector and Silvercorp Subscription Agreements
17th Mar 20257:33 amRNSAppointment of Non-Executive Director
12th Mar 20258:00 amRNSHalf-year Report
10th Mar 20257:01 amRNSFirm commitments received for AU$3.3 million
6th Mar 20257:00 amRNSASX Trading Halt
24th Feb 20257:55 amRNSMCB Project secures funding for development
31st Jan 20257:43 amRNSQuarterly Activities Report to December 2024
19th Dec 20249:00 amRNSSilvercorp Subscription
10th Dec 20245:15 pmRNSResult of Placing
10th Dec 20244:35 pmRNSProposed Placing to raise approximately £0.35 mill
18th Nov 20243:55 pmRNSResult of AGM
14th Nov 20247:20 amRNSMCB Project granted extension to meet funding
30th Oct 20247:00 amRNSQuarterly Activities Report and Appendix 5B
18th Oct 20247:56 amRNSNotice of AGM
7th Oct 20247:12 amRNSMCB Project and local workforce skills
30th Sep 202411:09 amRNSAnnual Financial Report
20th Sep 20247:28 amRNSDate of Annual General Meeting
19th Sep 20248:09 amRNSSilvercorp Subscription Agreement
16th Sep 20247:00 amRNSCorporate Funding Update
4th Sep 20247:55 amRNSMCB Project receives FPIC certification
31st Jul 20247:55 amRNSQuarterly Activities Report and Appendix 5B
15th Jul 20247:01 amRNSApproval of Sagay SDMP and change of broker
8th Jul 202412:31 pmRNSResult of General Meeting
7th Jun 20247:04 amRNSNotice of GM
8th May 20247:00 amRNSExec IR Director appointed and Board Update
1st May 202410:39 amRNSAmendment to Quarterly Cashflow Report
30th Apr 20248:11 amRNSQuarterly Activities Report and Appendix 5B
18th Apr 20247:09 amRNSSubscription Agreement with Silvercorp Metals

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.